Fundz

Who to call at Santhera Pharmaceuticals, and when

Fundz watches for the moments Santhera Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Santhera Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Santhera Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Santhera Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Santhera Pharmaceuticals Forms Exclusive Agreement with Biomedica for AGAMREE® Distribution in Russia.

Oct 09, 2025

Contract Type

agreement

PrattelnBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaPharmaceutical Manufacturingpharmaceuticals

Description

Santhera Pharmaceuticals has signed an exclusive agreement with Biomedica for the distribution of AGAMREE® (vamorolone) in Russia, aimed at treating Duchenne muscular dystrophy. The collaboration will enable access to AGAMREE for DMD patients, starting in Q1 2026, facilitating regional and national managed access programs.

Company Information

Company

Santhera Pharmaceuticals

Location

24 Hohenrainstrasse

Pratteln, Basel-Landschaft, Switzerland

About

Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.

Related People

Marc
Likely contact at this company
••••••••@••••••••

See Marc's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Santhera Pharmaceuticals's next move

Learn about Strategic plan

Santhera Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.